Vishala Chindalore

Statistics

Publications

Citations

1.1K

H-Index

Active since

1998

Affiliations

Pinnacle Clinical Research(Current)

Metroplex Clinical Research Center

Johns Hopkins Medicine

Clinical Research of West Florida

Johns Hopkins University

Vishala Chindalore is an author at Pinnacle Clinical Research specializing in pharmacology, systemic lupus erythematosus, and therapeutic monoclonal antibodies.

Publications per year

1998–2024

Publications

Sifalimumab, a Human Anti–Interferon‐α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose‐Escalation Study

Michelle Petri, Daniel J. Wallace, Alberto Spindler et al. · Arthritis & Rheumatism · 2013 · 240 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double‐blind, methotrexate‐controlled study of patients with active rheumatoid arthritis

Stanley Cohen, Tien‐Tsai Cheng, Vishala Chindalore et al. · Arthritis & Rheumatism · 2009 · 231 citations

Medicine, Pharmacology, Pharmacotherapy +16

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

D. J. Wallace, M. Pétri, Kyriakos A. Kirou et al. · Annals of the Rheumatic Diseases · 2011 · 228 citations

Pharmacy, Immunology, Pharmacology +17

Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus

Jodi L. Karnell, Yanping Wu, Nanette Mittereder et al. · Science Translational Medicine · 2021 · 117 citations

Life Sciences, Dermatology, Immunology +13

Adding Ultralow-Dose Naltrexone to Oxycodone Enhances and Prolongs Analgesia: A Randomized, Controlled Trial of Oxytrex

Vishala Chindalore, Richard Craven, Kevin Yu et al. · Journal of Pain · 2005 · 116 citations

Medicine, Anesthesiology, Pharmacology +13

1–5 of 11